Tagged with Pharma,

Pharma Dr. Osvaldo Ponchiroli, CEO of OP Pharma, discusses the expertise his company can offer to help navigate Italy’s regulatory environment, the outlook for medium-sized generics companies in Italy and OP’s plans for international expansion. Dr. Ponchiroli, you founded OP pharma in 1996 as a data management and generics company mainly…

Pharma Family-owned Laboratori Baldacci is something of a rare breed in an industry dominated by multinational players. The senior research manager discusses the history of the company as well as how it plans to leverage its portfolio of innovative products and internationalization to drive growth in future. Could you please provide…

Pharma Shire France’s General Manager, Andrew Obenshain, speaks optimistically about the leading market conditions in France, the corporate culture of a multinational company in a niche market, and building a rapport with government and patients. As an American working in France, what are your key observations about the differences and similarities…

Pharma Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Now part of the Sanofi group, as SanofiGenzyme, it benefits from the reach and resources of one of the world’s largest pharmaceutical companies with a shared commitment to improving the lives of patients. The general manager…

Pharma As CEO of the newly formed government agency Business France, Muriel Pénicaud is passionate about championing French innovation and creativity, particularly in life sciences. She tells us about her organization’s key objectives, ongoing efforts to change perceptions about France’s business environment, and her ‘bilingualism’ in the worlds of business and…

Pharma Alexander Zehnder discusses Sanofi’s sizable contribution to the Italian economy, manufacturing in Italy, and the country’s labyrinthine drug approval processes. What have been your main areas of focus and priorities since your appointment as head of Sanofi’s Italy and Malta operations in October 2014? Sanofi is in the midst of a transition from…

Pharma The dynamic Director of ESCP Europe’s Master in Biopharmaceutical Management talks about being the reference higher education institution for programs catering to the biopharma sector, plans for more international visibility, and some notable alumni of the university’s executive level curriculum. ESCP Europe appears to have a special connection to the…

Pharma Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in the Netherlands, the resulting second pillar of specialty products for the company and the growth ambitions for the affiliate over the next few years. You have extensive experience in the generics…

Pharma Thierry Guillot, president of Chugai Pharma France, talks about the challenge of transitioning from a small organization, which revolved around one main product into a larger entity capable of delivering multiple products and solutions; he also reveals how since 2008, Chugai and Roche have worked together on marketing and business…

Pharma CreaPharm Group’s CEO, Eric Placet, discusses the creation of his company, ambitions for growth, and the lessons learned throughout his leadership. He also emphasizes the relevance of the size of the business in optimizing performance. For the last 20 years, you have built the CreaPharm Group to the success that…

Pharma LEO Pharma is expanding its global presence and continuing its leading role in the number of skin disease patients treated and in thrombosis care. Head of the company’s French affiliate, the largest globally, Mr. Guillaume Clement shares his perspective on the company’s new initiatives in efforts to meet ambitious future…

Pharma Jan Pelle Mariëtte van der Velden-Roesink Jan Pelle (JP) and Mariëtte van der Velden-Roesink (MDR) of the Brabant Development Agency (BOM) explain how they strive to offer “red-carpet treatment” to foreign investors and local companies to ultimately strengthen a life sciences eco-system based on open innovation and interdisciplinarity. As an…